Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 4157313, 12 pages
http://dx.doi.org/10.1155/2016/4157313
Research Article

Reversal of Early Diabetic Nephropathy by Islet Transplantation under the Kidney Capsule in a Rat Model

1Key Laboratory of Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
2Department of Transplantation, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province 325000, China
3School of Pharmacy, Wenzhou Medical University, Wenzhou, Zhejiang Province 325000, China
4Department of Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China

Received 22 April 2016; Revised 15 August 2016; Accepted 23 August 2016

Academic Editor: Paolo Fiorina

Copyright © 2016 Yunqiang He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Yokoyama and T. Deckert, “Central role of TGF-β in the pathogenesis of diabetic nephropathy and macrovascular complications: a hypothesis,” Diabetic Medicine, vol. 13, no. 4, pp. 313–320, 1996. View at Google Scholar · View at Scopus
  2. M. Svensson, G. Sundkvist, H. J. Arnqvist et al., “Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS),” Diabetes Care, vol. 26, no. 10, pp. 2903–2909, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. Z. H. Liu, “Nephrology in China,” Nature Reviews Nephrology, vol. 9, no. 9, pp. 523–528, 2013. View at Publisher · View at Google Scholar
  4. S. S. Kim, J. H. Kim, and I. J. Kim, “Current challenges in diabetic nephropathy: early diagnosis and ways to improve outcomes,” Endocrinology and Metabolism, vol. 31, no. 2, pp. 245–253, 2016. View at Publisher · View at Google Scholar
  5. N. G. van der Sande, J. A. Dorresteijn, F. L. Visseren et al., “Individualized prediction of the effect of angiotensin receptor blockade on renal and cardiovascular outcomes in patients with diabetic nephropathy,” Diabetes, Obesity and Metabolism, 2016. View at Publisher · View at Google Scholar
  6. F.-F. Li, L.-Y. Fu, W.-L. Zhang et al., “Blood glucose fluctuations in type 2 diabetes patients treated with multiple daily injections,” Journal of Diabetes Research, vol. 2016, Article ID 1028945, 8 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. R. F. Saidi, “Current status of pancreas and islet cell transplantation,” International Journal of Organ Transplantation Medicine, vol. 3, no. 2, pp. 54–60, 2012. View at Google Scholar · View at Scopus
  8. J. Lundberg, S. Stone-Elander, X.-M. Zhang, O. Korsgren, S. Jonsson, and S. Holmin, “Endovascular method for transplantation of insulin-producing cells to the pancreas parenchyma in swine,” American Journal of Transplantation, vol. 14, no. 3, pp. 694–700, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Fioretto and M. Mauer, “Effects of pancreas transplantation on the prevention and reversal of diabetic nephropathy,” Contributions to Nephrology, vol. 170, pp. 237–246, 2011. View at Google Scholar
  10. P. Fiorina, G. Perseghin, F. De Cobelli et al., “Altered kidney graft high-energy phosphate metabolism in kidney-transplanted end-stage renal disease type 1 diabetic patients: a cross-sectional analysis of the effect of kidney alone and kidney-pancreas transplantation,” Diabetes Care, vol. 30, no. 3, pp. 597–603, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Fiorina, M. Venturini, F. Folli et al., “Natural history of kidney graft survival, hypertrophy, and vascular function in end-stage renal disease type 1 diabetic kidney-transplanted patients: beneficial impact of pancreas and successful islet cotransplantation,” Diabetes Care, vol. 28, no. 6, pp. 1303–1310, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. F. C. Brosius, C. C. Khoury, C. L. Buller, and S. Chen, “Abnormalities in signaling pathways in diabetic nephropathy,” Expert Review of Endocrinology and Metabolism, vol. 5, no. 1, pp. 51–64, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Ar'Rajab, B. Ahren, J. Alumets, L. Logdberg, and S. Bengmark, “Islet transplantation to the renal subcapsular space improves late complications in streptozotocin-diabetic rats,” European Surgical Research, vol. 22, no. 5, pp. 270–278, 1990. View at Publisher · View at Google Scholar · View at Scopus
  14. C. I. Araiza-Saldaña, E. F. Pedraza-Priego, J. E. Torres-Lõpez et al., “Fosinopril prevents the development of tactile allodynia in a streptozotocin-induced diabetic rat model,” Drug Development Research, vol. 76, no. 8, pp. 442–449, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. E. J. Zmuda, C. A. Powell, and T. Hai, “A method for murine islet isolation and subcapsular kidney transplantation,” Journal of Visualized Experiments, no. 50, Article ID e2096, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Lembert, J. Wesche, P. Petersen, M. Doser, H. D. Becker, and H. P. T. Ammon, “Areal density measurement is a convenient method for the determination of porcine islet equivalents without counting and sizing individual islets,” Cell Transplantation, vol. 12, no. 1, pp. 33–41, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Napoli, A. M. Davalli, M. F. Hirshman, R. Weitgasser, G. C. Weir, and E. S. Horton, “Islet transplantation under the kidney capsule fully corrects the impaired skeletal muscle glucose transport system of streptozocin diabetic rats,” The Journal of Clinical Investigation, vol. 97, no. 6, pp. 1389–1397, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Pichaiwong, K. L. Hudkins, T. Wietecha et al., “Reversibility of structural and functional damage in a model of advanced diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 24, no. 7, pp. 1088–1102, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. G. H. Tesch and T. J. Allen, “Rodent models of streptozotocin-induced diabetic nephropathy,” Nephrology, vol. 12, no. 3, pp. 261–266, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. A. R. Pepper, R. Pawlick, B. Gala-Lopez et al., “Diabetes is reversed in a murine model by marginal mass syngeneic islet transplantation using a subcutaneous cell pouch device,” Transplantation, vol. 99, no. 11, pp. 2294–2300, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Fiorina, F. Folli, G. Zerbini et al., “Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplants,” Journal of the American Society of Nephrology, vol. 14, no. 8, pp. 2150–2158, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. M.-K. Lu, X.-G. Gong, and K.-L. Guan, “mTOR in podocyte function: is rapamycin good for diabetic nephropathy?” Cell Cycle, vol. 10, no. 20, pp. 3415–3416, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Niranjan, B. Bielesz, A. Gruenwald et al., “The Notch pathway in podocytes plays a role in the development of glomerular disease,” Nature Medicine, vol. 14, no. 3, pp. 290–298, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. K. O. Alsaad and A. M. Herzenberg, “Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update,” The Journal of Clinical Pathology, vol. 60, no. 1, pp. 18–26, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. M. C. Iglesias-de la Cruz, F. N. Ziyadeh, M. Isono et al., “Effects of high glucose and TGF-β1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes,” Kidney International, vol. 62, no. 3, pp. 901–913, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. A. S. Awad, L. Huang, H. Ye et al., “Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy,” American Journal of Physiology-Renal Physiology, vol. 290, no. 4, pp. F828–F837, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. A. D. McClelland, M. Herman-Edelstein, R. Komers et al., “miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7,” Clinical Science, vol. 129, no. 12, pp. 1237–1249, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. H. W. Schnaper, T. Hayashida, S. C. Hubchak, and A.-C. Poncelet, “TGF-β signal transduction and mesangial cell fibrogenesis,” American Journal of Physiology—Renal Physiology, vol. 284, no. 2, pp. F243–F252, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Bessho, S. Mizuno, K. Matsumoto, and T. Nakamura, “Counteractive effects of HGF on PDGF-induced mesangial cell proliferation in a rat model of glomerulonephritis,” American Journal of Physiology—Renal Physiology, vol. 284, no. 6, pp. F1171–F1180, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Y. Chow, D. J. Nikolic-Paterson, E. Ozols, R. C. Atkins, B. J. Rollin, and G. H. Tesch, “Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice,” Kidney International, vol. 69, no. 1, pp. 73–80, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. K.-W. Kim, “Islet transplantation: a realistic alternative for the treatment of insulin deficient diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 66, supplement 1, pp. S11–S17, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. C. A. M. Tiemessen, C. W. E. Hoedemaekers, F. M. Van Iersel et al., “Intensive insulin therapy increases the risk of hypoglycemia in neurocritical care patients,” Journal of Neurosurgical Anesthesiology, vol. 23, no. 3, pp. 206–214, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Czech, E. Rdzanek, J. Pawȩska, O. Adamowicz-Sidor, M. Niewada, and M. Jakubczyk, “Drug-related risk of severe hypoglycaemia in observational studies: a systematic review and meta-analysis,” BMC Endocrine Disorders, vol. 15, no. 1, article 57, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Qian, E. Feldman, S. Pennathur, M. Kretzler, and F. C. Brosius, “From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy,” Diabetes, vol. 57, no. 6, pp. 1439–1445, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Fiorina, A. Vergani, R. Bassi et al., “Role of podocyte B7-1 in diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 25, no. 7, pp. 1415–1429, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. B.-L. Johansson, K. Borg, E. Fernqvist-Forbes, A. Kernell, T. Odergren, and J. Wahren, “Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus,” Diabetic Medicine, vol. 17, no. 3, pp. 181–189, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. J. E. Blau, M. R. Abegg, W. A. Flegel, X. Zhao, D. M. Harlan, and K. I. Rother, “Long-term immunosuppression after solitary islet transplantation is associated with preserved C-peptide secretion for more than a decade,” American Journal of Transplantation, vol. 15, no. 11, pp. 2995–3001, 2015. View at Publisher · View at Google Scholar · View at Scopus